HMGB1 and acute respiratory distress syndrome: Inhibiting RIP3 could protect mice against LPS-induced ARDS, at least in part, through reducing lung necrosis, decreasing inflammation and HMGB1 release in BALF, and weakening the lung neutrophil infiltration and protein leakage.